{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:28:27Z","timestamp":1776691707453,"version":"3.51.2"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.cbi.2018.04.026","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T11:12:27Z","timestamp":1524654747000},"page":"32-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Free fatty acid receptor 1 as a novel therapeutic target for type 2 diabetes mellitus-current status"],"prefix":"10.1016","volume":"289","author":[{"given":"Chinedum","family":"Eleazu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayogu","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Eleazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngozi","family":"Achi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2018.04.026_bib1","unstructured":"International Diabetes Federation. p. 13. Archieved from the original on 2016-03-22. Retrieved 21 March 2016."},{"key":"10.1016\/j.cbi.2018.04.026_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-pharmtox-011613-135945","article-title":"Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors","volume":"54","author":"Offermanns","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2018.04.026_bib3","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.294.5548.1866","article-title":"Nuclear receptors and lipid physiology: opening the X-files","volume":"294","author":"Chawla","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cbi.2018.04.026_bib4","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2010.10.012","article-title":"The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin","volume":"140","author":"Liou","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2018.04.026_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature01478","article-title":"Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40","volume":"422","author":"Itoh","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2018.04.026_bib6","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1016\/j.bmcl.2014.05.019","article-title":"Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus","volume":"24","author":"Defossa","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2018.04.026_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.numecd.2009.02.008","article-title":"G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids","volume":"20","author":"Del","year":"2010","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.cbi.2018.04.026_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbrc.2005.07.042","article-title":"Role of GPR40 in fatty acid action on the beta cell line INS-1E","volume":"335","author":"Shapiro","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2018.04.026_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.bjp.0706770","article-title":"2006 Pharmacological regulation of insulin secretion in Min6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules","volume":"148","author":"Briscoe","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2018.04.026_bib10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0006-291X(02)03064-4","article-title":"A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs","volume":"301","author":"Kotarsky","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2018.04.026_bib11","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.1021\/acs.jmedchem.6b00892","article-title":"The discovery, preclinical, and early clinical development of potent and selective GPR40 agonists for the treatment of type 2 diabetes mellitus (LY2881835, LY2922083, and LY2922470","volume":"59","author":"Chafiq","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2018.04.026_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1464-5491.2005.01505.x","article-title":"Studies of relationships between variation of the human G protein-coupled receptor 40 Gene and Type 2 diabetes and insulin release","volume":"22","author":"Hamid","year":"2005","journal-title":"Diabet. Med."},{"key":"10.1016\/j.cbi.2018.04.026_bib13","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s00125-010-1850-5","article-title":"Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass","volume":"53","author":"Fontes","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2018.04.026_bib14","doi-asserted-by":"crossref","first-page":"23561","DOI":"10.1074\/jbc.M702115200","article-title":"Regulation of the gene encoding GPR40, a fatty acid receptor expressed selectively in pancreatic \u03b2 cells","volume":"282","author":"Bartoov-Shifman","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2018.04.026_bib15","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1073\/pnas.1114350109","article-title":"Glucose activates free fatty acid receptor 1 gene transcription via phosphatidylinositol-3-kinase-dependent O-GlcNAcylation of pancreas duo-denum homeobox-1","volume":"109","author":"Kebede","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cbi.2018.04.026_bib16","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M211495200","article-title":"The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids","volume":"278","author":"Briscoe","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2018.04.026_bib17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/db06-1532","article-title":"GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo","volume":"56","author":"Latour","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2018.04.026_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cmet.2005.03.007","article-title":"The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse","volume":"1","author":"Steneberg","year":"2005","journal-title":"Cell Metabol."},{"key":"10.1016\/j.cbi.2018.04.026_bib19","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2337\/db08-0307","article-title":"Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion","volume":"57","author":"Edfalk","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2018.04.026_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.prostaglandins.2009.05.003","article-title":"Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis","volume":"89","author":"Ichimura","year":"2009","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.cbi.2018.04.026_bib21","doi-asserted-by":"crossref","first-page":"29248","DOI":"10.1074\/jbc.M705077200","article-title":"Identification of residues important for agonist recognition and activation in GPR40","volume":"282","author":"Sum","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2018.04.026_bib22","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1016\/j.bmcl.2016.10.074","article-title":"GPR40 agonists for the treatment of type 2 diabetes mellitus: the biological characteristics and the chemical space","volume":"26","author":"Chen","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2018.04.026_bib23","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.bmcl.2009.03.082","article-title":"Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists","volume":"19","author":"Humphries","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2018.04.026_bib24","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1007\/s00125-012-2650-x","article-title":"G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1","volume":"55","author":"Ferdaoussi","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2018.04.026_bib25","first-page":"982","article-title":"Deletion of GPR40 impairs glucose induced and high oral bioavailability","volume":"58","author":"Alquier","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2018.04.026_bib26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/db08-1233","article-title":"Overexpression of GPR40 inpancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice","volume":"58","author":"Nagasumi","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2018.04.026_bib27","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s00125-006-0305-5","article-title":"Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signaling","volume":"49","author":"Nolan","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2018.04.026_bib28","first-page":"275e280","article-title":"Free fatty acid receptor 1: a new drug target for type 2 diabetes?","volume":"36","author":"Mourad","year":"2012","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.cbi.2018.04.026_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11154-008-9101-5","article-title":"Beta-cell failure as a complication of diabetes","volume":"9","author":"Chang-Chen","year":"2008","journal-title":"Revised Endocrine Metabolism Disordord"},{"key":"10.1016\/j.cbi.2018.04.026_bib30","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/diabetes.52.10.2461","article-title":"A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes","volume":"52","author":"Kashyap","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2018.04.026_bib31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1021\/ml1000855","article-title":"Discovery of TAK-875: a potent, selective, and orally bioavailable GPR40 agonist","volume":"1","author":"Negoro","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2018.04.026_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17460441003605098","article-title":"Lipophilicity in drug discovery","volume":"5","author":"Waring","year":"2010","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.cbi.2018.04.026_bib33","first-page":"1","article-title":"Free fatty acid receptor 1 (FFAR1) as an emerging therapeutic target for type 2 diabetes mellitus: recent progress and prevailing challenges","author":"Li","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.cbi.2018.04.026_bib34","doi-asserted-by":"crossref","unstructured":"He Li, Qi H, Cheng C, Bin Xu, Heyao W, Ya-Qiu L. Discovery of potent and orally bioavailable GPR40 full agonists bearing thiophen-2-ylpropanoic acid scaffold. J. Med. Chem., DOI: 10.1021\/acs.jmedchem.6b01357.","DOI":"10.1021\/acs.jmedchem.6b01357"},{"key":"10.1016\/j.cbi.2018.04.026_bib35","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1016\/j.bmc.2015.07.028","article-title":"Optimization of 3-aryl-3-ethoxypropanoic acids and discovery of the potent GPR40 agonist DS-1558","volume":"23","author":"Takano","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2018.04.026_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/ml500391n","article-title":"Discovery of DS-1558: a potent and orally bioavailable GPR40 agonist","volume":"6","author":"Takano","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2018.04.026_bib37","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.bmcl.2011.10.118","article-title":"AMG 837: a potent, orally bioavailable GPR40 agonist","volume":"22","author":"Houze","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2018.04.026_bib38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/dna.2005.24.54","article-title":"A family of fatty acid binding receptors","volume":"24","author":"Brown","year":"2005","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.cbi.2018.04.026_bib39","unstructured":"Takeda Pharmaceutical Company Limited: Osaka, 2013; https:\/\/www.takeda.com\/news\/2013\/20131227_6117.html (Accessed May 26, 2016)."},{"key":"10.1016\/j.cbi.2018.04.026_bib40","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1016\/j.bmcl.2014.04.065","article-title":"Discovery of 3-aryl-3-ethoxypropanoic acids as orally active gpr40 Agonists","volume":"24","author":"Takano","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2018.04.026_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lfs.2013.11.010","article-title":"Novel gpr40 agonist As2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion","volume":"94","author":"Tanaka","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2018.04.026_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1124\/jpet.113.206466","article-title":"Chronic treatment with novel gpr40 agonists improve whole-body Glucose metabolism based on the glucose-dependent insulin secretion","volume":"346","author":"Tanaka","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2018.04.026_bib43","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1021\/jm2005699","article-title":"Identification of a potent and selective free fatty acid receptor 1 (FFA1\/GPR40) agonist with favorable physico-chemical and in vitro ADME properties","volume":"54","author":"Christiansen","year":"2011","journal-title":"Journal Medical Chemistry"},{"key":"10.1016\/j.cbi.2018.04.026_bib44","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1021\/jm8010178","article-title":"Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)\/GPR40), a potential target for the treatment of type II diabetes","volume":"51","author":"Christiansen","year":"2008","journal-title":"Journal Medical Chemistry"},{"key":"10.1016\/j.cbi.2018.04.026_bib45","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/13543784.2016.1189530","article-title":"Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development","volume":"25","author":"Zheng","year":"2016","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.cbi.2018.04.026_bib46","first-page":"20","article-title":"Targeting peroxisome proliferator-activated receptors using thiazolidinediones: strategy for design of novel antidiabetic drugs","volume":"2017","author":"Neelaveni","year":"2017","journal-title":"Int. J. Med. Chem."},{"key":"10.1016\/j.cbi.2018.04.026_bib47","article-title":"A novel free fatty acid receptor 1 (GPR40\/FFAR1) agonist, MR1704, enhances glucose-dependent insulin secretion and improves glucose homeostasis in rats","volume":"5","author":"Naoto","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.cbi.2018.04.026_bib48","article-title":"Discovery of phenylsulfonyl acetic acid derivatives with improved efficacy and safety as potent free fatty acid receptor 1 agonists for the treatment of type 2 diabetes","author":"Zheng","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2018.04.026_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00441-005-0017-z","article-title":"Free fatty acid receptor 1 (FFA(1)R\/GPR40) and its involvement in fatty-acid-stimulated insulin secretion","volume":"322","author":"Flodgren","year":"2005","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.cbi.2018.04.026_bib50","doi-asserted-by":"crossref","first-page":"394e401","DOI":"10.1016\/j.neures.2007.05.001","article-title":"Expression of free fatty acid receptor GPR40 in the central nervous system of adult monkeys","volume":"58","author":"Ma","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.cbi.2018.04.026_bib51","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1210\/en.2008-0111","article-title":"Modulation of osteoclastogenesis by fatty acids","volume":"149","author":"Cornish","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.cbi.2018.04.026_bib52","doi-asserted-by":"crossref","DOI":"10.1210\/en.2008-0111","article-title":"Modulation of osteoclastogenesis by fatty acids","volume":"149","author":"Cornish","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.cbi.2018.04.026_bib53","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M410922200","article-title":"Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40","volume":"280","author":"Hardy","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2018.04.026_bib54","doi-asserted-by":"crossref","first-page":"21131","DOI":"10.1074\/jbc.M115.644450","article-title":"\u03b2-arrestin recruitment and biased agonism at free fatty acid receptor 1","volume":"290","author":"Mancini","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2018.04.026_bib55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biocel.2016.03.012","article-title":"Epigenetic regulation of G Protein Coupled Receptor signaling and its implications in psychiatric disorders","volume":"77","author":"Shalini","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2018.04.026_bib56","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1100\/tsw.2001.489","article-title":"Extracellular and intracellular regulation of calcium homeostasis","volume":"1","author":"Bronner","year":"2001","journal-title":"Sci. World J."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717313522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717313522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:48:26Z","timestamp":1757857706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279717313522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":56,"alternative-id":["S0009279717313522"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2018.04.026","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Free fatty acid receptor 1 as a novel therapeutic target for type 2 diabetes mellitus-current status","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2018.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}